By blocking the lysosomal degradation pathway of E-cadherin, TMEM139 suppresses EMT, the migration and invasion capabilities of NSCLC cells in both cellular models, as well as the metastasis of NSCLC cells in animal models [96]. Here, TMEM139 is linked to non-small cell lung carcinoma.